/Investor DB

O2h Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Small Pharmasmallpharma.comJan 2021

Helus Pharma is a clinical-stage pharmaceutical company developing novel serotonergic agonists—synthetic molecules that activate serotonin pathways—as next-generation mental health therapies.

BiotechHealthtechMental HealthLondon

Eric So(Co-Founder, Executive Chairman)Carol Routledge(Executive Officer)George Tziras(Director)Khalid Howladar(Director)Marie Claire Layzell(Executive Officer, Director)Peter Rands(Executive Officer, Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.